Opto Circuits (India) is currently trading at Rs. 35.10, up by 4.15 points or 13.41% from its previous closing of Rs. 30.95 on the BSE.
The scrip opened at Rs. 32.50 and has touched a high and low of Rs. 35.45 and Rs. 32.50 respectively. So far 2607260 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 88.50 on 25-Jan-2013 and a 52 week low of Rs. 17.80 on 25-Jun-2013.
Last one week high and low of the scrip stood at Rs. 35.45 and Rs. 26.50 respectively. The current market cap of the company is Rs. 842.06 crore.
The promoters holding in the company stood at 28.22% while Institutions and Non-Institutions held 30.05% and 41.74% respectively.
Goldman Sachs is reportedly planning to buy 26% stake in Indian medical equipment maker Opto Circuits (India) for around Rs 300 crore. Following the acquisition, the investment banker will also appoint two members to the firm’s board.
The Global investment banker will acquire the stake through a combination of existing and fresh equity. The fresh infusion will be used to further expand the Opto Circuits’ medical device business.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: